Business Description
Welcure Drugs & Pharmaceuticals Ltd
ISIN : INE331C01025
Share Class Description:
BOM:524661: Shs DematerialisedCompare
Compare
Traded in other countries / regions
524661.India IPO Date
2000-11-27Description
Welcure Drugs & Pharmaceuticals Ltd is a pharmaceutical company. The company operates exclusively in a single business segment: the trading of medical products. The company's revenue is entirely derived from this segment, encompassing a range of activities from sourcing pharmaceutical products to facilitating their distribution in domestic and international markets.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.01 | |||||
Equity-to-Asset | 0.19 | |||||
Debt-to-Equity | 1.27 | |||||
Debt-to-EBITDA | -20.81 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 0.59 | |||||
Beneish M-Score | 9.79 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EPS without NRI Growth Rate | -88.2 | |||||
3-Year FCF Growth Rate | 22.9 | |||||
3-Year Book Growth Rate | 97.4 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 13.23 | |||||
9-Day RSI | 23.79 | |||||
14-Day RSI | 30.15 | |||||
3-1 Month Momentum % | -13.79 | |||||
6-1 Month Momentum % | -21.88 | |||||
12-1 Month Momentum % | -74.47 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.87 | |||||
Quick Ratio | 0.52 | |||||
Days Inventory | 162.26 | |||||
Days Sales Outstanding | 205.3 | |||||
Days Payable | 199.02 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 11.68 | |||||
Operating Margin % | -2.02 | |||||
Net Margin % | -4.65 | |||||
EBITDA Margin % | -1.62 | |||||
FCF Margin % | 0.47 | |||||
OCF Margin % | 0.47 | |||||
ROE % | -15.27 | |||||
ROA % | -3.61 | |||||
ROIC % | -2.37 | |||||
3-Year ROIIC % | -1.87 | |||||
ROC (Joel Greenblatt) % | -5.68 | |||||
ROCE % | -3.07 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shiller PE Ratio | 3.96 | |||||
Price-to-Owner-Earnings | 16.92 | |||||
PS Ratio | 0.07 | |||||
PB Ratio | 0.27 | |||||
Price-to-Tangible-Book | 0.27 | |||||
Price-to-Free-Cash-Flow | 16.15 | |||||
Price-to-Operating-Cash-Flow | 16.15 | |||||
EV-to-EBIT | -4.27 | |||||
EV-to-EBITDA | -4.29 | |||||
EV-to-Revenue | 0.07 | |||||
EV-to-FCF | 15.34 | |||||
Earnings Yield (Greenblatt) % | -23.41 | |||||
FCF Yield % | 6.68 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Welcure Drugs & Pharmaceuticals Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 3,655.383 | ||
| EPS (TTM) (₹) | -0.013 | ||
| Beta | 1.8559 | ||
| 3-Year Sharpe Ratio | 0.06 | ||
| 3-Year Sortino Ratio | 0.09 | ||
| Volatility % | 59.44 | ||
| 14-Day RSI | 30.15 | ||
| 14-Day ATR (₹) | 0.015848 | ||
| 20-Day SMA (₹) | 0.2325 | ||
| 12-1 Month Momentum % | -74.47 | ||
| 52-Week Range (₹) | 0.2 - 0.97909 | ||
| Shares Outstanding (Mil) | 1,235.94 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Welcure Drugs & Pharmaceuticals Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Welcure Drugs & Pharmaceuticals Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| 1.1:1 Stock Split | 2025-10-16 | 0.74 (-8.24%) |
Show
Entries
Welcure Drugs & Pharmaceuticals Ltd Frequently Asked Questions
What is Welcure Drugs & Pharmaceuticals Ltd(BOM:524661)'s stock price today?
The current price of BOM:524661 is ₹0.21. The 52 week high of BOM:524661 is ₹0.98 and 52 week low is ₹0.20.
When is next earnings date of Welcure Drugs & Pharmaceuticals Ltd(BOM:524661)?
The next earnings date of Welcure Drugs & Pharmaceuticals Ltd(BOM:524661) is .
Does Welcure Drugs & Pharmaceuticals Ltd(BOM:524661) pay dividends? If so, how much?
Welcure Drugs & Pharmaceuticals Ltd(BOM:524661) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Welcure Drugs & Pharmaceuticals Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers